Bridgeway Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-249,000
| Closed | -$138K | – | 1441 |
|
2022
Q4 | $138K | Hold |
249,000
| – | – | ﹤0.01% | 1167 |
|
2022
Q3 | $296K | Hold |
249,000
| – | – | 0.01% | 1043 |
|
2022
Q2 | $157K | Sell |
249,000
-31,000
| -11% | -$19.5K | ﹤0.01% | 1143 |
|
2022
Q1 | $319K | Buy |
280,000
+140,000
| +100% | +$160K | 0.01% | 1056 |
|
2021
Q4 | $315K | Sell |
140,000
-263,100
| -65% | -$592K | 0.01% | 1093 |
|
2021
Q3 | $1.38M | Sell |
403,100
-142,200
| -26% | -$486K | 0.03% | 733 |
|
2021
Q2 | $1.63M | Buy |
545,300
+134,500
| +33% | +$402K | 0.03% | 699 |
|
2021
Q1 | $1.33M | Sell |
410,800
-8,500
| -2% | -$27.5K | 0.02% | 767 |
|
2020
Q4 | $889K | Hold |
419,300
| – | – | 0.02% | 773 |
|
2020
Q3 | $491K | Hold |
419,300
| – | – | 0.01% | 891 |
|
2020
Q2 | $379K | Buy |
419,300
+9,300
| +2% | +$8.41K | 0.01% | 953 |
|
2020
Q1 | $343K | Sell |
410,000
-86,900
| -17% | -$72.7K | 0.01% | 882 |
|
2019
Q4 | $477K | Hold |
496,900
| – | – | 0.01% | 1010 |
|
2019
Q3 | $512K | Hold |
496,900
| – | – | 0.01% | 952 |
|
2019
Q2 | $894K | Buy |
496,900
+54,400
| +12% | +$97.9K | 0.01% | 771 |
|
2019
Q1 | $832K | Buy |
442,500
+163,500
| +59% | +$307K | 0.01% | 829 |
|
2018
Q4 | $329K | Sell |
279,000
-180,000
| -39% | -$212K | ﹤0.01% | 1109 |
|
2018
Q3 | $1.24M | Hold |
459,000
| – | – | 0.01% | 795 |
|
2018
Q2 | $877K | Hold |
459,000
| – | – | 0.01% | 925 |
|
2018
Q1 | $964K | Hold |
459,000
| – | – | 0.01% | 858 |
|
2017
Q4 | $932K | Hold |
459,000
| – | – | 0.01% | 863 |
|
2017
Q3 | $610K | Buy |
459,000
+250,000
| +120% | +$332K | 0.01% | 1037 |
|
2017
Q2 | $328K | Sell |
209,000
-80,000
| -28% | -$126K | ﹤0.01% | 1192 |
|
2017
Q1 | $933K | Sell |
289,000
-4,800
| -2% | -$15.5K | 0.01% | 836 |
|
2016
Q4 | $397K | Hold |
293,800
| – | – | 0.01% | 1160 |
|
2016
Q3 | $458K | Buy |
+293,800
| New | +$458K | 0.01% | 1124 |
|